These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12852282)

  • 1. [Mechanisms of action of antiarrhythmics in cardioversion of atrial fibrillation and atrial flutter].
    Davy JM; Raczka F; Beck L; Piot C
    Arch Mal Coeur Vaiss; 2003 May; 96 Spec No 4():20-9. PubMed ID: 12852282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
    Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
    Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
    J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gap junction modifier, GAP-134 [(2S,4R)-1-(2-aminoacetyl)-4-benzamido-pyrrolidine-2-carboxylic acid], improves conduction and reduces atrial fibrillation/flutter in the canine sterile pericarditis model.
    Rossman EI; Liu K; Morgan GA; Swillo RE; Krueger JA; Gardell SJ; Butera J; Gruver M; Kantrowitz J; Feldman HS; Petersen JS; Haugan K; Hennan JK
    J Pharmacol Exp Ther; 2009 Jun; 329(3):1127-33. PubMed ID: 19252062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New antiarrhythmic drugs for atrial flutter and atrial fibrillation: a conceptual breakthrough at last?
    Cosío FG; Delpón E
    Circulation; 2002 Jan; 105(3):276-8. PubMed ID: 11804977
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
    Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
    J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathophysiology and clinical management of atrial flatter].
    Fazekas T; Csanádi Z
    Orv Hetil; 2004 Jan; 145(4):155-65. PubMed ID: 14978881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation.
    Wazni O; Marrouche NF; Martin DO; Gillinov AM; Saliba W; Saad E; Klein A; Bhargava M; Bash D; Schweikert R; Erciyes D; Abdul-Karim A; Brachman J; Gunther J; Pisano E; Potenza D; Fanelli R; Natale A
    Circulation; 2003 Nov; 108(20):2479-83. PubMed ID: 14610012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial fibrillation: insights from clinical trials and novel treatment options.
    Blaauw Y; Crijns HJ
    J Intern Med; 2007 Dec; 262(6):593-614. PubMed ID: 18028181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The electrocardiology of atrial fibrillation].
    Costantini M; Crema A
    Ital Heart J Suppl; 2000 May; 1(5):632-40. PubMed ID: 10834128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective ablation or isolation of all pulmonary veins in atrial fibrillation -- when and for whom?
    Walczak F; Szumowski L; Urbanek P; Szufladowicz E; Derejko P; Kułakowski P; Baranowski R; Bodalski R; Kepski R; Zagrodzka M; Onish K; Bestry I; Konka M; Kuśnierczyk B; Maryniak A
    Kardiol Pol; 2006 Jan; 64(1):26-35; discussion 36-7. PubMed ID: 16444625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
    Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G
    Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of atrial fibrillation and atrial flutter: Part II.
    Aronow WS
    Cardiol Rev; 2008; 16(5):230-9. PubMed ID: 18708824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelationships between the autonomic nervous system and atrial fibrillation.
    Olshansky B
    Prog Cardiovasc Dis; 2005; 48(1):57-78. PubMed ID: 16194692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of IKr blocker nifekalant on atrial action potential duration after successful internal cardioversion of chronic atrial fibrillation.
    Kofune T; Watanabe I; Okubo K; Okumura Y; Masaki R; Shindo A; Saito S
    Pacing Clin Electrophysiol; 2005 May; 28(5):391-6. PubMed ID: 15869670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
    Eijsbouts S; Ausma J; Blaauw Y; Schotten U; Duytschaever M; Allessie MA
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):648-54. PubMed ID: 16836716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency catheter ablation of chronic atrial fibrillation guided by complex electrograms.
    Oral H; Chugh A; Good E; Wimmer A; Dey S; Gadeela N; Sankaran S; Crawford T; Sarrazin JF; Kuhne M; Chalfoun N; Wells D; Frederick M; Fortino J; Benloucif-Moore S; Jongnarangsin K; Pelosi F; Bogun F; Morady F
    Circulation; 2007 May; 115(20):2606-12. PubMed ID: 17502567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):442-7. PubMed ID: 14558294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part I: Molecular and ionic fundamentals of antiarrhythmic drug actions.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):430-41. PubMed ID: 14558293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rational bases for the therapy of supraventricular tachycardias and their management].
    Rostagno C; Bertini G; Padeletti L; Michelucci A; Del Pace S; Gensini GF
    Ann Ital Med Int; 1993; 8(4):235-43. PubMed ID: 8161480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.